Bacitracin / hydrocortisone / neomycin / polymyxin b topical Pregnancy and Breastfeeding Warnings
Bacitracin / hydrocortisone / neomycin / polymyxin b topical is also known as: Cortisporin Ointment
Bacitracin / hydrocortisone / neomycin / polymyxin b topical Pregnancy Warnings
This drug should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.
US FDA pregnancy category: Not formally assigned to a pregnancy category.
Animal studies with this combination drug have not been reported. Corticosteroids have been found to be teratogenic in rabbits when applied topically at concentrations of 0.5% and 15%. There are no controlled data in human pregnancy.
Bacitracin / hydrocortisone / neomycin / polymyxin b topical Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-Topical application should result in very low levels in breast milk and present negligible risk to the infant.
-Only water-miscible creams or gels should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.
-Any amount of drug should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.
See also
References for pregnancy information
- "Product Information. Cortisporin (bacitracin/HC/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc (2022):
References for breastfeeding information
- "Product Information. Cortisporin (bacitracin/HC/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc (2022):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.